Persistence of community-acquired respiratory distress syndrome toxin-producing Mycoplasma pneumoniae in refractory asthma

Chest

Volumn 140, Issue 2, 2011, Pages 401-407

  Peters, Jay ^a   Singh, Harjinder ^a   Brooks, Edward G ^a   Diaz, Joseph ^b   Kannan, Thirumalai R ^a   Coalson, Jacqueline J ^a   Baseman, Janet G ^c   Cagle, Marianna ^a   Baseman, Joel B ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Allergy Asthma and Immunology Associates of South Texas   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIAL TOXIN; CLARITHROMYCIN; COMMUNITY ACQUIRED RESPIRATORY DISTRESS SYNDROME TOXIN; DNA; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; P1 ADHESIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; ASTHMA; BLOOD ANALYSIS; CONTROLLED STUDY; DNA DETERMINATION; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NOSE SECRETION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; REFRACTORY ASTHMA; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS; THROAT CULTURE; TREATMENT DURATION;

EID: 80051486855     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0221     Document Type: Article

References (25)

1. Bel EH, Sousa A, Fleming L et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI) [published online ahead of print November 23, 2010]. Thorax. doi:10.1136/thx.2010.138552.
2. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med. 1994;148(7):727-732. (Pubitemid 24218479)
3. Hahn DL, McDonald R. Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma? Ann Allergy Asthma Immunol. 1998;81(4):339-344. (Pubitemid 28498999)
4. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. 1991; 266(2):225-230.
5. Gil JC, Cedillo RL, Mayagoitia BG, Paz MD. Isolation of Mycoplasma pneumoniae from asthmatic patients. Ann Allergy. 1993;70(1):23-25. (Pubitemid 23042030)
6. Yano T, Ichikawa Y, Komatu S, Arai S, Oizumi K. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am J Respir Crit Care Med. 1994;149(5):1348-1353. (Pubitemid 24147080)
7. Kraft M, Cassell GH, Henson JE, et al. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med. 1998;158(3):998-1001. (Pubitemid 28449473)
8. Leaver R, Weinberg EG. Is Mycoplasma pneumoniae a precipitating factor in acute severe asthma in children? S Afr Med J. 1985;68(2):78-79. (Pubitemid 15003535)
9. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A. 2006;103(17):6724-6729.
10. Kannan TR, Musatovova O, Balasubramanian S, et al. Mycoplasma pneumoniae community acquired respiratory distress syndrome toxin expression reveals growth phase and infection-dependent regulation. Mol Microbiol. 2010;76(5):1127-1141.
11. Winchell JM, Thurman KA, Mitchell SL, Thacker WL, Fields BS. Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation. J Clin Microbiol. 2008;46(9):3116-3118.
12. Muir MT, Cohn SM, Louden C, Kannan TR, Baseman JB. Novel toxin assays implicate Mycoplasma pneumoniae in prolonged ventilator course and hypoxemia. Chest. 2011;139(2):305-310.
13. Techasaensiri C, Tagliabue C, Cagle M, et al. Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among Mycoplasma pneumoniae strains. Am J Respir Crit Care Med. 2010;182(6):797-804.
14. Dallo SF, Kannan TR, Blaylock MW, Baseman JB. Elongation factor Tu and E1 beta subunit of pyruvate dehydrogenase complex act as fibronectin binding proteins in Mycoplasma pneumoniae. Mol Microbiol. 2002;46(4):1041-1051. (Pubitemid 35370592)
15. Dallo SF, Su CJ, Horton JR, Baseman JB. Identification of P1 gene domain containing epitope(s) mediating Mycoplasma pneumoniae cytoadherence. J Exp Med. 1988;167(2):718-723. (Pubitemid 18073673)
16. European Network for Understanding Mechanisms of Severe Asthma. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J. 2003;22(3):470-477.
17. Kannan TR, Coalson JJ, Cagle M, et al. Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model. J Infect Dis. In press.
18. Johnston SL, Blasi F, Black PN, Martin RJ, Farrell DJ, Nieman RB;TELICAST Investigators. The effect of telithromycin in acute exacerbations of asthma. N Engl J Med. 2006;354(15):1589-1600.
19. Sutherland ER, King TS, Icitovic N, et alNational Heart, Lung and Blood Institute's Asthma Clinical Research Network. A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol. 2010;126(4):747-753.
20. Nilsson AC, Björkman P, Persson K. Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol. 2008;8:93.
21. Marmion BP, Williamson J, Worswick DA, Kok TW, Harris RJ. Experience with newer techniques for the laboratory detection of Mycoplasma pneumoniae infection: Adelaide, 1978-1992. Clin Infect Dis. 1993;17(suppl 1):S90-S99. (Pubitemid 23227113)
22. Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol. 2002;40(1):165-171. (Pubitemid 34027620)
23. Atkinson TP, Duffy LB, Pendley D, Dai Y, Cassell GH. Deficient immune response to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc. 2009;30(2):158-165.
24. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J. 1995;14(6):471-477.
25. Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS ONE. 2009;4(10):e7562.